Background: Recently bismuth-based nanoparticles have attracted increasing attention as a dose amplification agent in radiation therapy due to high atomic number, high photoelectric absorption, low cost, and low toxicity. Objectives: This study aims to calculate physical aspects of dose enhancement of bismuth-based nanoparticles in the presence of brachytherapy source by Monte Carlo simulation and an analytical method for low mono-energy. Materials and methods: After simulation and validation brachytherapy sources (Iodine-125 and Ytterbium-169) by Monte Carlo code, bismuth-based nanoparticles (bismuth, bismuth oxide, bismuth sulfide, and bismuth ferrite) were modeled in the sizes of 50 nm and 100 nm for two concentrations of 10 and 20 mg/ml. Dose enhancement factors for the bismuth-based nanoparticles were measured at both brachytherapy sources. Furthermore, the dose amplification was calculated with an analytic method at 30 keV mono-energy. Results: Dose enhancement factor was greatest with pure bismuth nanoparticles, followed by bismuth oxide, bismuth sulfide and bismuth ferrite for both radiation source and simulation methods. The dose amplification for the bismuthbased nanoparticles increased with increasing size and concentration of nanoparticles. Conclusion: The physical aspect dose enhancement of the nanoparticles was shown by Monte Carlo and analytic method. The results have proved bismuth-based nanoparticles deserve further study as a radiosensitizer.
Introduction
Over the two last decades, extensive studies have been drawn on nanoparticles as a radiosensitizer in radiation therapy. Although radiation therapy is a well known noninvasive method in cancer therapy, we have faced serious limitation to protect the surrounding healthy tissue. This challenge could cause a serious problem, specifically for patients who prescribed to receive high radiation dose. To circumvent this restriction, nanoparticles (with a high atomic number) as radiosensitizer can be considered in the tumor. By adding the nanoparticles as a physical radiosensitizer to the tumor region, the local dose distribution increases around the nanoparticles compared to normal tissue due to the high absorption coefficient of the nanoparticles [1] . Radiosensitization mechanisms can be categorized into three items: physical, biological and chemical processes. From a physical point of view, high Z atomic number nanoparticles could enhance photoelectric interactions (σ ~Z E ⁄ , atomic number, Z, the energy of a photon, E) and Auger electron in sub-MeV energies [2, 3] . Therefore, nanoparticles have the significant ability on radiation dose amplification when kilovoltage energy such as brachytherapy source is applied [4, 5] . Various kinds of high atomic number nanoparticles have been widely investigated as radiosensitizer such as gold, bismuth, platinum, tungsten, and gadolinium [6] [7] [8] . Although the most studies have been focused on gold nanoparticles, recently bismuth-based nanoparticles as a material with high atomic number (Z = 82), high photoelectric absorption, low cost, and low toxicity have been drawn considerable attention in radiotherapy [9] [10] [11] [12] . For more than three centuries, bismuth metal compounds are extensively employed in medical applications. Compounds containing bismuth have been used for the treatment of gastroenterology illnesses, syphilis, skin lesions, and Helicobacter pylori infection [13, 14] . In the size of nano, numerous studies (in vitro and in vivo experiments) have shown that bismuth-based nanoparticles could enhance the local dose within the tumor, thanks to their high X-ray attenuation coefficient. For example, uniform size bismuth nanoparticle (Bi) was prepared and investigated as computed tomography (CT) contrast agent for gastrointestinal tract imaging [15] . Moreover, the nanoparticles were detected as target tracing in CT/fluorescence imaging [16] . In the field of radiation therapy, the effect of bismuth nanoparticles on radiation dose enhancement was investigated for breast cancer [10] . Bismuth sulfide (Bi 2 S 3 ) nanoparticles as a biocompatible bismuth-based radiosensitizer were introduced in imaging and radiation therapy [17] . In vitro and in vivo studies demonstrated that the Bi 2 S 3 nanoparticles have the ability to improve the efficacy of both radiation and photo-thermal therapy for cancer treatment [18, 19] . The other kind of bismuth-based nanoparticles which was investigated as radiosensitizer is bismuth oxide nanoparticles (Bi 2 O 3 ) . Results of the studies established the effect of Bi 2 O 3 nanoparticles on radiation enhancement by clonogenic and modeling assays [20] [21] [22] . In our previous work, we confirmed the suitability of multifunction bismuth ferrite nanoparticles (BiFeO 3 ) as a magnetic local dose enhancement. Whereas bismuth ferrite has both dose amplification and magnetic property due to bismuth and iron elements, the nanoparticles were evaluated as a multimodal imaging contrast agent in magnetic resonance imaging (MRI) and computed tomography (CT) [6] .
In this study, firstly, the 
Material and methods

Brachytherapy sources
125 I, SelectSeed 130.002 as low dose rate (LDR) and 169 Yb, 4140 as high dose rate (HDR) brachytherapy sources were chosen from the studies by Karaiskos et al. [24] and Medich et al. [25] , respectively. The geometry of the sources is illustrated in Figure 1a . The 125 I source consists of a cylinder rod with an outer diameter of 0.510 mm and a length of 3.40 mm which is covered with a silver halide layer (AgCl/AgI) in 3.00 µm thick. Titanium capsule with hemisphere end shape (radius, 0.4 mm) and length 4.5 mm is covered the active length of the source (3.40 mm). High dose rate source ( 169 Yb) core is ytterbium oxide (6.9 g/cm 3 ) length 3.6 mm (active length) which is encapsulated by stainless steel with hemisphere shape in end (radius, 0.45 mm) and length of 4.8 mm. The stainless steel cable (6.90 g/cm 3 ) in the shape of a cylinder with a diameter of 0.9 mm and length 1.95 mm is attached in the source. Details dimension sources are mentioned in Figure 1a .
Monte Carlo simulations
Calculation of TG-43 parameters
High dose rate (HDR) and low dose rate (LDR) brachytherapy sources were modeled by general-purpose Monte Carlo NParticle Transport (MCNP6) code published by the Los Alamos National Laboratory. TG-43 parameters such as dose rate, air-kerma strength, dose rate constant, radial dose function, and anisotropy function in order to validate code were calculated from the below formula:
( ) ( , ) Eq 1. ( , ) is dose rate in distance r, and polar angle θ from a line source in water. S K and Λ denote air-kerma strength and dose rate constant, respectively. 
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Radiation sources were placed in a spherical water phantom to catch all scattering radiation and outside of sphere was void. Radial dose g(r), and the anisotropy function F(r,θ) were calculated by detectors which were simulated as series of cones, centered in radiation sources with angles from 0° to 180° degree and radial distance from 1 to 10 cm.
Nanoparticles dose enhancement
MCNP-Monte Carlo
Radiation sources ( 125 I and 169 Yb) were considered in center of sphere water phantom with radius 20 cm and a cubic tumor with a dimension of 1×1×1 cm 3 was in 1 cm from the sources.
The cube was divided into cells with a dimension of 2×2×2 mm 3 and each cell was filled with smaller cells according to the concentration of nanoparticles (Figure 1b) . [23, 26, 27] . A based dose ; = 2 was chosen as dose absorbed in water cell without nanoparticles. Photon flux (Φ), the number of photons (N ph ) incident on the nanoparticles and the probability (P) of photoelectric interaction on nanoparticles are given by follow equations:
where Φ is photon flux, E is the energy of a photon, (
is mass absorption coefficient of water at energy E;
where G HI is the number of photons interacted by NPs and r is the radius of NPs;
where p is a probability of photoelectric interaction on nanoparticles, Q RS is denthe sity of nanoparticles and T RS = .
Based on the equations, emitted photoelectrons from a nanoparticle is:
and the total number of nanoparticles G RS in cell slab for a given concentration, C (mg/g), is obtained by: where T is the thickness of the cell. Calculated results for radial dose function, g(r), (from 1 to 10 cm with a distance of 1 cm) and the anisotropy function, F(r,θ) (at the radial distance of r = 1 cm) for the 125 As it is clear from Figure 2 , the results show a good agreement between calculated TG-43 parameters from the simulation and previous studies [24, 25] .
Dose enhancement
Dose enhancement factor for bismuth-based nanoparticles such as Bi, Bi 2 O 3 , Bi 2 S 3 , and BiFeO 3 at the presence of 125 I and 169 Yb brachytherapy sources was calculated by MCNP6 code.
The factor for nanoparticles with two concentrations of 10 and 20 mg at the size of 50 nm and 100 nm for both the brachytherapy sources is shown in Figures 3, 4 
Discussion
Possessing a high atomic number and cost-effective advantages, bismuth nanoparticle deserves thorough studies to show bismuth-based nanoparticles as a promising candidate in radiotherapy for cancer treatment. In this work, we simulated two brachytherapy source 125 I and 169 Yb for calculating the effect of the bismuth-based nanoparticles on radiation dose amplification by MCNP code. Moreover, we compared the dose enhancement factor of various bismuth-based nanoparticles with an analytical method for mono-energetic photon sources. As it is clear from both analytical and MCNP code methods, pure bismuth has highest dose enhancement and bismuth ferrite is lowest among the aforementioned bismuth based-nanoparticles. However, bismuth ferrite nanoparticle has lowest DEF, the nanoparticle has magnetic and liner optical property which can employ for hyperthermia and photodynamic therapy. Moreover, the BiFeO 3 nanoparticle may have the ability to apply for magnetic resonance image (MRI), and computed tomography (CT) as multimodal contrast agent due to Fe (Z=56) as a magnetic particle (MRI) and Bi (Z=82) with high photoelectric absorption (CT imaging) [6] . However, in this study, we have not decided to compare results of both methods of simulation (analytic and MCNP code) due to differences in conditions and radiation source, dose enhancement factors calculated of an analytical method is lower than MCNP simulation. Analytical simulation has some limitation [26] , it doesn't consider photoelectron interactions of neighboring bismuth nanoparticles while Monte Carlo simulation involves interactions of neighboring nanoparticles. Monte Carlo simulation accounts all photoelectric, Auger electron and Compton photon and electron, while the analytic method just considers photoelectrons coefficient absorption.
Conclusions
The dose enhancement effect of bismuth-based nanoparticles (Bi, Bi 2 O 3 , Bi 2 S 3, and BiFeO 3 ) was compared by Monte Carlo (MCNP-Code) and analytic simulation. Based on results of simulation and analytical methods pure bismuth nanoparticles and bismuth oxide have the highest dose enhancement factor in comparison with bismuth sulfide and bismuth ferrite. DEF increases with increasing concentration and size of nanoparticles. Results of analytical and Monte Carlo simulation express the physical aspect of radiation dose amplification from bismuth-based nanoparticles. Further experimental studies need to carry out in which the nanoparticles are considered as a physical radiosensitizer to improve the efficiency of radiation therapy.
